| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/1999 | EP0908179A1 Treatment of cell-mediated immune diseases |
| 04/14/1999 | EP0908178A1 Partial liquid breathing of fluorocarbons |
| 04/14/1999 | EP0908177A1 Procedure to form pharmaceutical compositions in spherical pills or granules of controlled and sustained action that contain as active agent Bromazepam and pharmaceutical compositions obtained by said procedure |
| 04/14/1999 | EP0908176A1 Intravenous administration form of thalidomide for the therapy of immunologic diseases |
| 04/14/1999 | EP0908169A2 Composition for use as a wound dressing |
| 04/14/1999 | EP0907751A2 Dna, rna and a protein useful for detection of a mycobacterial infection |
| 04/14/1999 | EP0907742A2 Cyclic nucleotide phosphodiesterase |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907737A1 Il-6 mutein |
| 04/14/1999 | EP0907736A2 Cc-type chemokines |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
| 04/14/1999 | EP0907724A2 Von willebrand factor multimerase |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0907666A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/14/1999 | EP0907659A1 Synthetic inhibitors of hepatitis c virus ns3 protease |
| 04/14/1999 | EP0907653A1 Process for the preparation of penam and penem derivatives |
| 04/14/1999 | EP0907652A1 Immunosuppressive compounds and methods |
| 04/14/1999 | EP0907651A1 Antineurodegenerative ergoline derivatives |
| 04/14/1999 | EP0907650A1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 04/14/1999 | EP0907649A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 04/14/1999 | EP0907646A1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 04/14/1999 | EP0907644A1 Pharmaceutical preparation |
| 04/14/1999 | EP0907643A1 Compounds with growth hormone releasing properties |
| 04/14/1999 | EP0907637A1 Phenylalamine derivatives as integrin inhibitors |
| 04/14/1999 | EP0907635A1 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 04/14/1999 | EP0907633A1 New synthetic catechol derivatives, method for production and use thereof |
| 04/14/1999 | EP0907632A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 04/14/1999 | EP0907631A1 Inorganic ion receptor-active compounds |
| 04/14/1999 | EP0907378A1 Concentrated antibody preparation |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907374A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 04/14/1999 | EP0907373A1 Use of il-12 and ifn-alpha for the treatment of infectious diseases |
| 04/14/1999 | EP0907372A1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
| 04/14/1999 | EP0907369A1 Materials and methods for treatment of plaquing diseases |
| 04/14/1999 | EP0907368A1 Novel heparin binding peptides |
| 04/14/1999 | EP0907366A1 Combination therapy for treatment of erectile dysfunction |
| 04/14/1999 | EP0907365A1 Novel formulation |
| 04/14/1999 | EP0907364A1 Pharmaceutical compositions |
| 04/14/1999 | EP0907363A1 8-aminoquinolines |
| 04/14/1999 | EP0907362A1 Il-8 receptor antagonists |
| 04/14/1999 | EP0907361A1 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 04/14/1999 | EP0907360A1 Method for maintaining an existing level of body fat and/or body weight |
| 04/14/1999 | EP0907356A1 Aerodynamically light particles for pulmonary drug delivery |
| 04/14/1999 | EP0907351A1 Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite |
| 04/14/1999 | EP0907350A2 A barrier cream comprising hexamethylenetetramine or derivative thereof |
| 04/14/1999 | EP0907318A1 Antioxidant compound |
| 04/14/1999 | EP0862577B1 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them |
| 04/14/1999 | EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
| 04/14/1999 | EP0794782A4 Cobalt schiff base compounds |
| 04/14/1999 | EP0767777B1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 04/14/1999 | EP0754173B1 Method for purifying diacetyl rhein |
| 04/14/1999 | EP0748221B1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors |
| 04/14/1999 | EP0737072B1 USE OF SIMPLE AND CONJUGATED DEXTRANS in the manufacture of a medicament for PREVENTING OR REDUCING THE RISK OF INFECTION BY BACTERIAL PATHOGENS |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | EP0721456B1 Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 04/14/1999 | EP0698010B1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 04/14/1999 | EP0683760B1 Dehydrogenation processes and equipment therefor |
| 04/14/1999 | EP0680320B1 Stable oral ci-981 formulation and process of preparing same |
| 04/14/1999 | EP0652879B1 1-azaadamantane derivatives as 5-ht4 agonists or antagonists and/or 5-ht3 antagonists |
| 04/14/1999 | EP0626952B1 Hypolipidaemic benzothiazepine compounds |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |
| 04/14/1999 | EP0584285B1 Treatment of schizophrenia by cholinesterase inhibitors |
| 04/14/1999 | EP0510068B1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1214080A Glycorprotein B of RFHV/KSHV subfamily of herpes viruses |
| 04/14/1999 | CN1214052A Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 04/14/1999 | CN1214051A Induction of immune responese against desired determinants |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/14/1999 | CN1214049A Therapeutic compounds |
| 04/14/1999 | CN1214048A Benzopyran derivatives having leukotriene-antagonistic action |
| 04/14/1999 | CN1214047A Novel aromatic piperazines derived from substituted cycloazanes, method for prepairing same, pharmaceutical compsns, and use thereof as drugs |
| 04/14/1999 | CN1214046A 4,5-dihydronaphth [1,2-C] isoxazoles and derivatives thereof having CNS activity |
| 04/14/1999 | CN1214043A Benzyl(idene)-lactam derivatives, their prepn. and their use as selective (ant) agaonists of 5-ht1A-and/or 5-ht1D receptors |
| 04/14/1999 | CN1214041A Sulfonated amino acid derivatives and metalloproteinase inhibitors contg. same |
| 04/14/1999 | CN1214039A Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 04/14/1999 | CN1213979A Mask for treating cold |
| 04/14/1999 | CN1213970A Method for treating autism |
| 04/14/1999 | CN1213969A Method for treating excessive aggression |
| 04/14/1999 | CN1213968A Use of (+)-'alpha'-(2,3-dimethyoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 04/14/1999 | CN1213967A Benzothiophenes, formulations containing same, and methods |
| 04/14/1999 | CN1213966A Method for treating bipolar disorder |
| 04/14/1999 | CN1213965A Use of antiarrhythmic compounds for reducing post-infarction morality |
| 04/14/1999 | CN1213964A Antiglucocorticoid drug |
| 04/14/1999 | CN1213962A Method for solubilising hydrophylic materials (E. G. proteins) in hydrophobic solvent |
| 04/14/1999 | CN1213539A Polygonatum sibiricum fructosans homologic mixture medicines |
| 04/14/1999 | CN1213535A Cosmetic skin lightening product for topical application |
| 04/14/1999 | CN1213514A 天然咖啡因电解质饮料 Natural caffeine electrolyte drinks |
| 04/14/1999 | CN1042936C Substituted aminoquinolone compound, its application and medicinal compsns. containing same |
| 04/14/1999 | CN1042935C 2-cyano-3-hydroxy acrylic amide compound, its prepn. applications and medicinal compsns. |
| 04/14/1999 | CN1042933C Benzoylguanidine, prepn. of same and application as pharmaceutical and pharmaceutical containing same |
| 04/14/1999 | CN1042896C External compound corticoid prepn. |
| 04/14/1999 | CN1042895C Medicines compsition and its method for treating drop syndrome and de-addition of drugaddic |
| 04/13/1999 | US5894070 Applying onto the hard tissue site an agent comprising a chitosan |
| 04/13/1999 | US5894019 Topically applied pharmaceutical composition, method of preparing it and its use |
| 04/13/1999 | CA2173494C Process and antiparasitic intermediates for doramectin |